Prot # BAY 86-4875: Multcenter, Open-Label Study to Evaluate the Safety and Efficacy(by blinded reading) of Gadobutrol-Enhanced Magnetic Resonance Angiography(MRA) After a Single Injection of 0.1 mmol/kg of Gadobutrol in Subjects with Known or Suspected R

Project: Research project

Project Details

Effective start/end date7/1/113/31/13


  • Bayer HealthCare Pharmaceuticals, Inc. (Prot # BAY 86-4875)